EUVIMEDEUVIMED entdecken
Open Access

Detection of Barrett’s Esophagus Prior to Development of Esophageal and Esophagogastric Junction Adenocarcinoma

Michelle Russin, Matthew Harbrecht, Ankit Mishra, Dhiraj Peddu, Matthew Kubina, Joy W Chang, Jennifer A Burns, Maria E Arasim, Joel H Rubenstein

Clinical Gastroenterology and Hepatology · 2025

DOI: 10.1016/j.cgh.2025.02.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2025. Verfasst von Michelle Russin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan. Hauptthemen laut MEDLINE: Barrett Esophagus, Adenocarcinoma, Esophageal Neoplasms, Esophagogastric Junction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCI NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Guidelines differ on the definition of Barrett's esophagus (BE). We aimed to estimate the detection rate of esophagogastroduodenoscopy (EGD) with biopsy for BE, using longitudinal outcome of adenocarcinoma of the esophagus or esophagogastric junction (EAC, EGJAC) as the gold standard. METHODS: We performed retrospective analyses of US Veterans with EAC/EGJAC between 2017 and 2021 who had an EGD before cancer diagnosis. We reviewed a random sample of 200 cases of EAC and 100 cases of EGJAC to tabulate the detection rate of EGD with biopsy, stratified by Siewert classification (S1 or S2). RESULTS: After manual review, there were 136 S1 and 108 S2 cases. Among patients with endoscopic suspicion of BE who had biopsies, 96.8% of S1 and 97.9% of S2 had intestinal metaplasia (IM). BE defined as ≥1 cm with IM had a detection rate of 66.2% for S1 and 39.8% for S2. When restricted to EGDs with appropriate biopsies, the detection rate of ≥1 cm with IM improved to 70.3% in S1 and 41.4% in S2. Seventy-three percent of S1 cases and 90% of S2 cases without BE diagnosed were related to lack of endoscopic suspicion for BE. BE or a visible lesion was present in 70% of photographs from EGDs not suspected of having BE by the original endoscopist. CONCLUSIONS: IM seems required for development of EAC and likely EGJAC. EGD with biopsy had only modest rate for detecting a precursor state for subsequent adenocarcinoma and was lower for S2 compared with S1. Variability in endoscopic suspicion, including segments

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Barrett EsophagusAdenocarcinomaEsophageal NeoplasmsEsophagogastric JunctionHumansMaleRetrospective StudiesFemaleMiddle AgedEndoscopy, Digestive SystemAgedBiopsyUnited States

Stichwörter der Autor:innen

Barrett EsophagusEsophageal NeoplasmsEsophagogastroduodenoscopyMass ScreeningSensitivity

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
  • Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
  • Veterans Affairs Center for Clinical Management Research, LTC Charles S. Kettles Veterans Affairs Medical Center, Ann Arbor, Michigan.
  • Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan; Veterans Affairs Center for Clinical Management Research, LTC Charles S. Kettles Veterans Affair…

Förderung

  • NIDDK NIH HHS
  • NCI NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institutes of Health
  • National Institutes of Health National Cancer Institute

Zitieren

APA

Russin, M., Harbrecht, M., Mishra, A., Peddu, D., Kubina, M., Chang, J. W., Burns, J. A., Arasim, M. E., & Rubenstein, J. H. (2025). Detection of Barrett’s Esophagus Prior to Development of Esophageal and Esophagogastric Junction Adenocarcinoma. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2025.02.016

Vancouver

Russin M, Harbrecht M, Mishra A, Peddu D, Kubina M, Chang JW, et al. Detection of Barrett’s Esophagus Prior to Development of Esophageal and Esophagogastric Junction Adenocarcinoma. Clinical Gastroenterology and Hepatology. 2025. doi:10.1016/j.cgh.2025.02.016

BibTeX
@article{Russin2025,
  author = {Russin, Michelle and Harbrecht, Matthew and Mishra, Ankit and Peddu, Dhiraj and Kubina, Matthew and Chang, Joy W and Burns, Jennifer A and Arasim, Maria E and Rubenstein, Joel H},
  title = {Detection of Barrett’s Esophagus Prior to Development of Esophageal and Esophagogastric Junction Adenocarcinoma},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2025},
  doi = {10.1016/j.cgh.2025.02.016}
}
Kostenlos starten →